CClinicalTrials.gg
CompletedNCT01123798Updated Jun 15, 2011

The Use of Near Infrared Spectroscopy in the Diagnosis of Acute Compartment Syndrome in Injured Soldiers

An observational study in Acute Compartment Syndrome, sponsored by J&M Shuler. Completed at 1 site in Germany. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-06-15.

Sponsored by J&M Shuler · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to define the reliability and accuracy of Near Infrared Spectroscopy (NIRS) in the detection of intra-compartmental tissue perfusion in injured and noninjured extremities over time. The investigators hypothesize that this technology, combined with vital signs, intracompartmental pressures and clinical examinations, will be useful in diagnosing acute compartment syndrome (ACS), monitoring patients at risk for ACS, and evaluating the adequacy of fasciotomy in patients treated for ACS.

02

Conditions studied

  • Acute Compartment Syndrome

Keywords

  • near infrared spectroscopy
  • lower extremity injury
03

In context

Compartment Syndromes

75 studies on the registry are indexed under Compartment Syndromes; 12 are open to participants now.

This study's planned enrollment of 300 is above the median of 110 across 30 observational studies indexed under Compartment Syndromes.

Browse Compartment Syndromes studies →

Lead sponsor

J&M Shuler is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Active duty OIF/OEF military personnel who have been air evacuated from theater to Landstuhl Regional Medical Center (LRMC). Ambulatory, self-care volunteers from the LRMC outpatient spine center will be identified to serve as controls for Cohort 1.

Inclusion criteria

  • 18-65 years old
  • male or female
  • active duty servicemen who have been evacuated from OIF or OEF through LRMC

Exclusion criteria

Exclusion Criteria:

  • patients not willing to provide consent
  • patients in whom application of NIRS monitoring is viewed as an impediment to casualty care
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)

Groups and cohorts

  • Stable controls

    Uninjured soldiers to provide normative data for stable physiological status

    Device: near-infrared spectroscopy

  • Critical controls

    Critically injured soldiers with no lower extremity traumatic injuries (excepting skin abrasions and small/superficial fragmentation wounds) to provide normative data for the "shock" physiological status.

    Device: near-infrared spectroscopy

  • Lower extremity trauma

    Soldiers with severe traumatic lower extremity injuries in stable and shock physiologic status. This is the investigational cohort.

    Device: near-infrared spectroscopy

Interventions

  • Devicenear-infrared spectroscopy

    Non-invasive monitoring device applied on the surface of the skin that emits harmless red light to measure tissue perfusion.

06

What researchers measure

Primary outcomes

  1. NIRS values in various physiologic states (stable control, critically injured control, lower extremity injury)

    Time frame: 24-48 hours from hospital admission

07

Study locations

1 site
  • Landstuhl Regional Medical Center
    Landstuhl, Germany
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 15, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01123798
Lead sponsor
J&M Shuler
Collaborators
United States Department of Defense, Somanetics Corporation
First posted
May 14, 2010
Start date
Feb 2010
Primary completion
Jan 2011
Completion
Jan 2011
Last update
Jun 15, 2011

Study contacts

Brett Freedman, MD
principal investigator · Landstuhl Regional Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion